Retinal central artery occlusion in a young woman after ten days of a drospirenone-containing oral contraceptive (Yasmin)

Thrombosis and Haemostasis

Volumn 98, Issue 2, 2007, Pages 473-474

  Girolami, Antonio ^a   Vettore, Silvia ^a   Tezza, Fabiana ^a   Girolami, Bruno ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DROSPIRENONE PLUS ETHINYLESTRADIOL; NADROPARIN; VASOPRESSIN; WARFARIN;

ABDOMINAL PAIN; ADULT; AMBLYOPIA; ARTICLE; CASE REPORT; CENTRAL RETINA ARTERY OCCLUSION; DIABETES INSIPIDUS; DRUG WITHDRAWAL; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LIMB PAIN; ORAL CONTRACEPTION; PRIORITY JOURNAL; VISUAL ACUITY;

ADOLESCENT; ANDROSTENES; ANTICOAGULANTS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; PROGESTERONE CONGENERS; RETINAL ARTERY OCCLUSION;

EID: 34547892620     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-02-0131     Document Type: Article

References (15)

1. Oelkers W. Drospirenone. A new progestogen with antimineralcorticoid activity, resembling natural progesterone. Eur J Contracept Reprod Health Care 2000; 5 (Suppl 3): 17-24.
2. Heinemann LA, Dinger J. Safety of a new oral contraceptive containing drospirenone. Drug Saf 2004; 27: 1001-1018.
3. Thorneycroft IH. Yasmin: the reason why. Eur J Contracept Reprod Health Care 2002; 7 (Suppl 3): 13-18.
4. Pearce HM, Layton D, Wilton LW, et al. Deeep vein thrombosis and pulmonary embolism reported in the prescription event monitoring study of Yasmin. Brit J Clin Pharmac 2005; 60: 98-102.
5. Van Grootheest K, Vrieling T. Thromboembolism associated with the new contraceptive Yasmin. Brit Med J 2003; 326: 257-257.
6. Sheldon P. Dutch GPs warned against new contraceptive pill. Br Med J 2002; 324: 869.
7. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and risk of venous thrombosis. New Eng J Med 2001; 344: 1527-1535.
8. Vayà A, Mira Y, Ferrando F, et al. Transient ischemic attack associated with the new contraceptive Yasmin. Thromb Res 2003; 112: 121-123.
9. Cabou C, Lacroix I, Roncalli J, et al. Infarctus du myocarde chez une jeune femme fumeuse sous contraception orale. Arch Moe Coeur Vaiss 2006; 99: 80-85.
10. Girolami A, Stevanato F, Lazzaro AR. Bilateral ileofemoral thrombophlebitis after 10 contraceptive pills in a 24-year old woman with antithrombin deficiency. Acta Hematol 1988; 79: 118-119.
11. Girolami A, Simioni P, Sartori MT, et al. Oral contraceptives caused thrombosis in a monoclonal twin with protein C deficiency while the other without medication remained asymptomatic. Blood Coag Fibrinolysis 1992; 3: 119-120.
12. Kemmeren JM, Tanis BC, van der Bosh MA, et al. Risk of arterial thrombosis in relation to oral contraception (ratio) study: oral contraceptives and the risk of ischemic stroke. Stroke 2002; 33: 1202-1208.
13. Tanis BC, der Bosch MA, Kemmeren JM, et al. Oral contraceptives and risk of myocardial infarction. New Eng J Med 2001; 345: 1787-1793.
14. Van Vliet HA, Winkel TA, Noort I, et al. Prothrombotic changes in users of combined contraceptives containing drospirenone and cyprotenone acetate. J Thromb Haemost 2004; 2: 2060-2062.
15. Chasan-Taber L, Stampfer M. Oral contraceptives and myocardial infarction. The search for the smoking gun. New Eng J Med 2001; 345: 1841-1842.